Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting

ConferenceLYMPHIR®Positive

AI Analysis

Summary

Citius Oncology announced it will present Phase 1 combination study data for LYMPHIR® at the 2026 American Society of Clinical Oncology Annual Meeting.

Clinical Trial Data

Phase

Phase 1

Importance:5/10

Sentiment:

0.30

oncologycombination therapyASCOPhase 1

Related Companies

$CTXR

Read the original article

Published by yahoo_finance on May 26, 2026 12:00 PM

Read Original